Feature | November 11, 2013

Increased Cardiovascular Risk in Men Using Testosterone Therapy Prompts Warning

cardiac diagnostics testosterone jama

November 11, 2013 — Men undergoing testosterone therapy had a 29 percent greater risk of heart attack, stroke and death according to a study of a "real world" population of men. An accompanying editorial in JAMA by an endocrinologist with the Perelman School of Medicine at the University of Pennsylvania notes that the mounting evidence of a signal of cardiovascular risk warrants cautious testosterone prescribing and additional investigation.
 
An estimated 2.9 percent of U.S. men over 40 years old are prescribed testosterone therapy, yet there are limited randomized trial data examining the long term benefits and risks. 
 
A study of patients in the VA system compared 1,223 men taking testosterone with 7,489 men not using testosterone and found a greater percentage of deaths, heart attacks and strokes in the testosterone group. Approximately one in five men not taking the therapy had such an event, whereas more than one in four men taking testosterone had a heart attack, stroke or died over a three year period. 
 
"We do not know if this risk extends to men who are taking testosterone for 'low T syndrome' or younger men taking it for physical enhancement, as there is a lack of long term safety data of testosterone therapy in men," said Anne Cappola, M.D., Sc.M., associate professor of medicine, Division of Endocrinology, Diabetes and Metabolism, Perelman School of Medicine, University of Pennsylvania and associate editor, JAMA. "But the men who were taking testosterone in this study were slightly healthier to begin with and surprisingly had a higher risk of catastrophic events."
 
Cappola notes that additional information from the ongoing T Trial — a randomized trial of 800 men aged 65 and older with diminished walking ability, interest in sex, energy, memory or iron levels in blood who will receive testosterone gel or placebo for one year — may provide important guidance to older men who meet current recommendations for testosterone therapy. Until then, Cappola notes "prescribers and patients should be wary."
 
For more information: jama.jamanetwork.com

Related Content

News | Cardiac Diagnostics

Aug. 13, 2024 – The traditional lipid panel may not give the full picture of cholesterol-related heart disease risk for ...

Home August 15, 2024
Home
Feature | Cardiac Diagnostics | By Robert L. Quigley, MD, DPhil

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes ...

Home January 23, 2024
Home
News | Cardiac Diagnostics

September 5, 2023 — GE HealthCare announced the launch of a handheld, wireless ultrasound imaging system designed for ...

Home September 05, 2023
Home
Feature | Cardiac Diagnostics | By Kelly Patrick

The global ambulatory diagnostic cardiology market was valued at $2.6 billion in 2022 and is forecast to rise to $3.3 ...

Home May 15, 2023
Home
News | Cardiac Diagnostics

February 8, 2023 — Results of research that identified new causes of Atherosclerotic Coronary Artery Disease, or ASCAD ...

Home February 08, 2023
Home
News | Cardiac Diagnostics

September 15, 2022 - Happitech has announced the launch of its FastStart Research app. The Amsterdam-based digital ...

Home September 15, 2022
Home
Feature | Cardiac Diagnostics | by Kelly Patrick

Like most healthcare markets, the diagnostic cardiology market has had a bumpy ride in recent years. The COVID-19 ...

Home August 23, 2022
Home
Feature | Cardiac Diagnostics | By Adam Saltman, MD, PhD

Before opining on the future of cardiac health, I think it’s important to define what “cardiac health” actually is. If ...

Home May 04, 2022
Home
News | Cardiac Diagnostics

January 31, 2022 — Scientists have developed an artificial intelligence (AI) system that can analyze eye scans taken ...

Home January 31, 2022
Home
News | Cardiac Diagnostics

November 10, 2021 — Abbott released new global market research from its Beyond Intervention initiative, the company’s ...

Home November 10, 2021
Home
Subscribe Now